» Articles » PMID: 24586264

Tempol, an Intracellular Antioxidant, Inhibits Tissue Factor Expression, Attenuates Dendritic Cell Function, and is Partially Protective in a Murine Model of Cerebral Malaria

Abstract

Background: The role of intracellular radical oxygen species (ROS) in pathogenesis of cerebral malaria (CM) remains incompletely understood.

Methods And Findings: We undertook testing Tempol--a superoxide dismutase (SOD) mimetic and pleiotropic intracellular antioxidant--in cells relevant to malaria pathogenesis in the context of coagulation and inflammation. Tempol was also tested in a murine model of CM induced by Plasmodium berghei Anka infection. Tempol was found to prevent transcription and functional expression of procoagulant tissue factor in endothelial cells (ECs) stimulated by lipopolysaccharide (LPS). This effect was accompanied by inhibition of IL-6, IL-8, and monocyte chemoattractant protein (MCP-1) production. Tempol also attenuated platelet aggregation and human promyelocytic leukemia HL60 cells oxidative burst. In dendritic cells, Tempol inhibited LPS-induced production of TNF-α, IL-6, and IL-12p70, downregulated expression of co-stimulatory molecules, and prevented antigen-dependent lymphocyte proliferation. Notably, Tempol (20 mg/kg) partially increased the survival of mice with CM. Mechanistically, treated mice had lowered plasma levels of MCP-1, suggesting that Tempol downmodulates EC function and vascular inflammation. Tempol also diminished blood brain barrier permeability associated with CM when started at day 4 post infection but not at day 1, suggesting that ROS production is tightly regulated. Other antioxidants-such as α-phenyl N-tertiary-butyl nitrone (PBN; a spin trap), MnTe-2-PyP and MnTBAP (Mn-phorphyrin), Mitoquinone (MitoQ) and Mitotempo (mitochondrial antioxidants), M30 (an iron chelator), and epigallocatechin gallate (EGCG; polyphenol from green tea) did not improve survival. By contrast, these compounds (except PBN) inhibited Plasmodium falciparum growth in culture with different IC50s. Knockout mice for SOD1 or phagocyte nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (gp91(phox-/-)) or mice treated with inhibitors of SOD (diethyldithiocarbamate) or NADPH oxidase (diphenyleneiodonium) did not show protection or exacerbation for CM.

Conclusion: Results with Tempol suggest that intracellular ROS contribute, in part, to CM pathogenesis. Therapeutic targeting of intracellular ROS in CM is discussed.

Citing Articles

Tempol improves optic nerve histopathology and ultrastructures in cisplatin-induced optic neuropathy in rats by targeting oxidative stress-Endoplasmic reticulum stress-Autophagy signaling pathways.

Alsemeh A, Hulail M, Mokhtar H, Eldemerdash R, Banatean-Dunea I, Fericean L Front Cell Neurosci. 2023; 17:1256299.

PMID: 37868197 PMC: 10585113. DOI: 10.3389/fncel.2023.1256299.


Insight into SARS-CoV-2 Omicron variant immune escape possibility and variant independent potential therapeutic opportunities.

Alam M Heliyon. 2023; 9(2):e13285.

PMID: 36744070 PMC: 9886571. DOI: 10.1016/j.heliyon.2023.e13285.


NADPH Oxidase: a Possible Therapeutic Target for Cognitive Impairment in Experimental Cerebral Malaria.

Kumar S, Prakash Babu P Mol Neurobiol. 2021; 59(2):800-820.

PMID: 34782951 DOI: 10.1007/s12035-021-02598-1.


A novel antioxidant ergothioneine PET radioligand for in vivo imaging applications.

Behof W, Whitmore C, Haynes J, Rosenberg A, Tantawy M, Peterson T Sci Rep. 2021; 11(1):18450.

PMID: 34531467 PMC: 8446031. DOI: 10.1038/s41598-021-97925-w.


Brief report: Tempol, a novel antioxidant, inhibits both activated T cell and antigen presenting cell derived cytokines in-vitro from COVID-19 patients.

Mathi K, Rosenberg-Hasson Y, Maecker H, Carlo D, Moss R Clin Immunol. 2021; 231:108828.

PMID: 34425240 PMC: 8378988. DOI: 10.1016/j.clim.2021.108828.


References
1.
Metz J, Smith D, Mick R, Lustig R, Mitchell J, Cherakuri M . A phase I study of topical Tempol for the prevention of alopecia induced by whole brain radiotherapy. Clin Cancer Res. 2004; 10(19):6411-7. DOI: 10.1158/1078-0432.CCR-04-0658. View

2.
Pabon A, Carmona J, Burgos L, Blair S . Oxidative stress in patients with non-complicated malaria. Clin Biochem. 2003; 36(1):71-8. DOI: 10.1016/s0009-9120(02)00423-x. View

3.
Watson S . Platelet activation by extracellular matrix proteins in haemostasis and thrombosis. Curr Pharm Des. 2009; 15(12):1358-72. DOI: 10.2174/138161209787846702. View

4.
von Montfort C, Matias N, Fernandez A, Fucho R, Conde de la Rosa L, Martinez-Chantar M . Mitochondrial GSH determines the toxic or therapeutic potential of superoxide scavenging in steatohepatitis. J Hepatol. 2012; 57(4):852-9. PMC: 3445734. DOI: 10.1016/j.jhep.2012.05.024. View

5.
Krishna M, Russo A, Mitchell J, Goldstein S, Dafni H, Samuni A . Do nitroxide antioxidants act as scavengers of O2-. or as SOD mimics?. J Biol Chem. 1996; 271(42):26026-31. DOI: 10.1074/jbc.271.42.26026. View